HRMY Harmony Biosciences Holdings, Inc.
Nasdaq · Health Care · Pharmaceutical Preparations · Market cap $2.3B · $39.64 on 2026-10-02
Buy (Payback/Ten Cap)Tier BDetailed (TTM)
Price moves
1 week-4%
1 month-6%
3 months6%
6 months43%
YTD3%
1 year45%
Off 52w high-9%
52w range$26–$43
Price history
Show year-end prices
| Year | Close |
|---|---|
| 2020 | $36.15 |
| 2021 | $42.64 |
| 2022 | $55.1 |
| 2023 | $32.3 |
| 2024 | $34.41 |
| 2025 | $37.42 |
| 2026-10-02 (latest) | $39.64 |
Buy (MOS)
$24
$24
Sticker
$48
$48
Ten Cap
$60
$60
Payback Time
$95
$95
Price
$40
$40
Valuation
| Buy (MOS) 50% of Sticker | $23.86 | -40% |
|---|---|---|
| Ten Cap 10× owner earnings | $60.37 | 52% |
| Payback Time 8-year FCF payback | $95.29 | 140% |
| Sticker Rule #1 intrinsic value | $47.73 | 20% |
| Windage growth g | 15.0% | |
| Future P/E (min 2g, 10y median) | 15.4× | |
| P/E · 10y median | 12.8× | 15.4× |
| EPS TTM 2026-06-30 | $3.09 | |
| FCF yield | 15.2% | |
| Revenue · net income last FY | $868M | $159M |
Big Five 8/11 tests ≥10%
| 10y | 5y | 1y | |
|---|---|---|---|
| ROIC | 17% | 19% | 15% |
| Sales growth | – | 40% | 22% |
| EPS growth | – | – | 8% |
| BVPS growth | – | 32% | 31% |
| OCF growth | – | – | 58% |
| Debt payoff (yrs of FCF) | 0.4 |
Events
next report ~2026-11-03
Next report ≈ 2026-11-03 · SEC filings ·Yahoo Finance